RGC
NASDAQ · Pharmaceuticals
Regencell Bioscience Holding
$5.92
+0.13 (+2.25%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
-61.66%
YTD
-71.18%
Open$5.74
Previous Close$5.79
Day High$6.05
Day Low$5.66
52W High$69.00
52W Low$4.51
Volume—
Avg Volume233.7K
Market Cap2.95B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$27.08
Below
SMA 200
$18.57
Below
RSI (14)
63.8
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.66B | 3.76B | 3.59B |
| Net Income | 706.46M | 788.49M | 815.65M |
| Profit Margin | 19.3% | 21.0% | 22.7% |
| EBITDA | 1.06B | 1.04B | 1.04B |
| Free Cash Flow | 809.03M | 638.27M | 648.55M |
| Rev Growth | +1.6% | +15.1% | +20.8% |
| Debt/Equity | 0.23 | 0.28 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |